Low-dose Interleukin-2 Therapy in Autoimmune and Inflammatory Diseases: Facts and Hopes.

Zhan-Guo Li,Jing He,Miao
DOI: https://doi.org/10.1016/j.scib.2022.12.024
IF: 18.9
2022-01-01
Science Bulletin
Abstract:Autoimmune diseases(AIDs)are characterized by impaired function of regulatory T(Treg)cells and excessive activation of effector T(Teff)cells.Immunosuppressive agents and corticos-teroids have long been the cornerstone of treatment for these dis-eases.However,these medications may cause life-threatening infections and other severe adverse effects.To resolve this dilemma,safe and more effective therapeutic approaches are urgently needed.
What problem does this paper attempt to address?